NUCLITHERA AS
Developing targeted alpha and beta emitters for metastatic cancer treatment.
Översikt
- 7
- Anställda
- 3.2milj NOK
- Omsättning
- 2023
- Grundat
Nyckelbeslutsfattare
Øyvind S. Bruland
CMO
Ada Repetto-Llamazares
CSO
Morten Lande
Board Member
Roy Hartvig Larsen
CTO
+1 fler kontakter i Funnelfeedr
Beskrivning
NucliThera a.s is a specialized research and development company focused on innovative cancer therapies. The core mission involves creating targeted short-range radionuclides, specifically alpha- and beta-emitters, for treating metastatic cancers. These high-energy nuclides are chemically linked to...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Okänt
- Juridisk form
- Aksjeselskap
- Momsnummer
- Okänt
Beslutsfattare
5 kontakter i FunnelfeedrØyvind S. Bruland
CMO
Ada Repetto-Llamazares
CSO
Morten Lande
Board Member
Roy Hartvig Larsen
CTO
Ludvik Sandnes
CEO, CFO
Liknande företag
20 liknande företag i Funnelfeedr
ONCOINVENT SOLUTIONS AS
45 anställdaNorwegian biotech transforming cancer care via direct alpha therapy.
Isofol Medical AB (publ)
10–19 anställdaDeveloping next-generation folate drug to improve cancer treatment efficacy.
SACRA Therapeutics AB
0 anställdaSACRA pioneers novel RNA-targeting therapies for incurable cancers.
ARTBIO AS
21 anställdaDeveloping novel alpha radioligand therapies to redefine cancer care.
BioGaia Pharma AB
0 anställdaDeveloping and out-licensing novel biotherapeutic platforms from microbiome research.
Utforska mer
Frågor om NUCLITHERA AS
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo